APLIF (Appili Therapeutics) Price-to-Operating-Cash-Flow : (As of Sep. 21, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-09-21), Appili Therapeutics's share price is $0.0255. Appili Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.00. Hence, Appili Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Appili Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

APLIF's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.18
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Appili Therapeutics's Cash Flow from Operations per share for the three months ended in Jun. 2024 was $-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 53.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 22.20% per year.

During the past 7 years, Appili Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 53.00% per year. The lowest was -40.60% per year. And the median was -7.20% per year.

Appili Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Appili Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Price-to-Operating-Cash-Flow Chart

Appili Therapeutics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Appili Therapeutics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Appili Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Appili Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Appili Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Appili Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Appili Therapeutics's Price-to-Operating-Cash-Flow falls into.

Appili Therapeutics Price-to-Operating-Cash-Flow Calculation

Appili Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.0255	/	-0.003
	=

Appili Therapeutics's Share Price of today is $0.0255.
Appili Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Appili Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Appili Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

APLI:Canada

Address

1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8

Website

https://www.appilitherapeutics.com

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.